Clinical Trial Update: The Metabolic Impact of Intermittent Carbohydrate Restriction in Individuals With Type 2 Diabetes [NA]

View source ↗

Summary

A clinical trial is evaluating the metabolic effects of intermittent carbohydrate restriction in adults with type 2 diabetes; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Non-alcoholic Fatty Liver Disease
• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Hvidovre University Hospital | Conditions: Diabetes Mellitus, Type 2, Overweight and Obesity | NA | Status: RECRUITING